Chupeng Ling , Yiwen Zhang , Chengguang Hu , Naying Liao , Jinlong Zhang , Yuanping Zhou , Wei Yang
{"title":"Early prediction of hepatocellular carcinoma using a risk-embedded longitudinal attention model","authors":"Chupeng Ling , Yiwen Zhang , Chengguang Hu , Naying Liao , Jinlong Zhang , Yuanping Zhou , Wei Yang","doi":"10.1016/j.bspc.2025.108897","DOIUrl":null,"url":null,"abstract":"<div><div>Hepatocellular carcinoma (HCC) frequently arises in patients with liver cirrhosis, and biannual ultrasound surveillance is a cost-effective strategy for its early detection. Longitudinal ultrasound images from routine follow-ups offer critical information for clinical HCC prediction, yet existing models struggle to capture their temporal dynamics. We present the risk embedded and longitudinal attention network (ReLANet), a deep learning framework that fuses diagnostic indicators of cirrhosis progression with cumulative risk data through a spatiotemporal architecture. By incorporating an age-dependent cumulative risk embedding and a longitudinal attention mechanism, ReLANet accommodates variable-length image sequences and dynamically evaluates their predictive value. In experiments on 6,170 samples from 619 cirrhosis patients, ReLANet achieved an area under the receiver operating characteristic curve of 80.2% (95% CI: 75.7%–84.4%), with 75.5% accuracy, 71.0% sensitivity, and 75.8% specificity, outperforming contemporary sequence models. These results demonstrate that ReLANet effectively integrates spatiotemporal and cumulative risk information from longitudinal ultrasound data, offering a state-of-the-art tool to enhance early HCC detection in at-risk populations.</div></div>","PeriodicalId":55362,"journal":{"name":"Biomedical Signal Processing and Control","volume":"113 ","pages":"Article 108897"},"PeriodicalIF":4.9000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Signal Processing and Control","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1746809425014089","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Hepatocellular carcinoma (HCC) frequently arises in patients with liver cirrhosis, and biannual ultrasound surveillance is a cost-effective strategy for its early detection. Longitudinal ultrasound images from routine follow-ups offer critical information for clinical HCC prediction, yet existing models struggle to capture their temporal dynamics. We present the risk embedded and longitudinal attention network (ReLANet), a deep learning framework that fuses diagnostic indicators of cirrhosis progression with cumulative risk data through a spatiotemporal architecture. By incorporating an age-dependent cumulative risk embedding and a longitudinal attention mechanism, ReLANet accommodates variable-length image sequences and dynamically evaluates their predictive value. In experiments on 6,170 samples from 619 cirrhosis patients, ReLANet achieved an area under the receiver operating characteristic curve of 80.2% (95% CI: 75.7%–84.4%), with 75.5% accuracy, 71.0% sensitivity, and 75.8% specificity, outperforming contemporary sequence models. These results demonstrate that ReLANet effectively integrates spatiotemporal and cumulative risk information from longitudinal ultrasound data, offering a state-of-the-art tool to enhance early HCC detection in at-risk populations.
期刊介绍:
Biomedical Signal Processing and Control aims to provide a cross-disciplinary international forum for the interchange of information on research in the measurement and analysis of signals and images in clinical medicine and the biological sciences. Emphasis is placed on contributions dealing with the practical, applications-led research on the use of methods and devices in clinical diagnosis, patient monitoring and management.
Biomedical Signal Processing and Control reflects the main areas in which these methods are being used and developed at the interface of both engineering and clinical science. The scope of the journal is defined to include relevant review papers, technical notes, short communications and letters. Tutorial papers and special issues will also be published.